|
1
|
Canadian Cancer Society/National Cancer
Institute of Canada: Canadian Cancer Statistics. Toronto, ON: ISSN:
0835-29762005
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nau KC and Lewis WD: Multiple myeloma:
diagnosis and treatment. Am Fam Physician. 78:853–859.
2008.PubMed/NCBI
|
|
4
|
Fotoohi AK, Assaraf YG, Moshfegh A,
Hashemi J, Jansen G, Peters GJ, Larsson C and Albertioni F: Gene
expression profiling of leukemia T-cells resistant to methotrexate
and 7-hydroxy-methotrexate reveals alterations that preserve
intracellular levels of folate and nucleotide biosynthesis. Biochem
Pharmacol. 77:1410–1417. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kelloff GJ, Crowell JA, Steele VE, Lubet
RA, Malone WA, Boone CW, Kopelovich L, Hawk ET, Lieberman R,
Lawrence JA, et al: Progress in cancer chemoprevention: development
of diet-derived chemopreventive agents. J Nutr. 130(Suppl):
467S–471S. 2000.PubMed/NCBI
|
|
6
|
Chiantore MV, Vannucchi S, Mangino G,
Percario ZA, Affabris E, Fiorucci G and Romeo G: Senescence and
cell death pathways and their role in cancer therapeutic outcome.
Curr Med Chem. 16:287–300. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Meier P and Vousden KH: Lucifer’s
labyrinth-ten years of path finding in cell death. Mol Cell.
28:746–754. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lavrik IN, Golks A and Krammer PH:
Caspases: pharmacological manipulation of cell death. J Clin
Invest. 115:2665–2672. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kadowaki H, Nishitoh H and Ichijo H:
Survival and apoptosis signals in ER stress: The role of protein
kinases. J Chem Neuroanat. 28:93–100. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oyadomari S and Mori M: Roles of
CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ.
11:381–389. 2004. View Article : Google Scholar
|
|
11
|
Kim I, Xu W and Reed JC: Cell death and
endoplasmic reticulum stress: disease relevance and therapeutic
opportunities. Nat Rev Drug Discov. 7:1013–1030. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ron D and Walter P: Signal integration in
the endoplasmic reticulum unfolded protein response. Nat Rev Mol
Cell Biol. 8:519–529. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oakes SA, Lin SS and Bassik MC: The
control of endoplasmic reticulum-initiated apoptosis by the BCL-2
family of proteins. Curr Mol Med. 6:99–109. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rong Y and Distelhorst CW: Bcl-2 protein
family members: versatile regulators of calcium signaling in cell
survival and apoptosis. Annu Rev Physiol. 70:73–91. 2008.
View Article : Google Scholar
|
|
15
|
Lee KW, Bode AM and Dong Z: Molecular
targets of phyto-chemicals for cancer prevention. Nat Rev Cancer.
11:211–218. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dumontet C and Jordan MA:
Microtubule-binding agents: a dynamic field of cancer therapeutics.
Nat Rev Drug Discov. 9:790–803. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gasiorowski K, Lamer-Zarawska E, Leszek J,
Parvathaneni K, Yendluri BB, Błach-Olszewska Z and Aliev G:
Flavones from root of Scutellaria baicalensis Georgi: drugs of the
future in neurodegeneration? CNS Neurol Disord Drug Targets.
10:184–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li-Weber M: New therapeutic aspects of
flavones: the anticancer properties of Scutellaria and its main
active constituents Wogonin, Baicalein and Baicalin. Cancer Treat
Rev. 35:57–68. 2009. View Article : Google Scholar
|
|
19
|
He L, Lu N, Dai Q, Zhao Y, Zhao L, Wang H,
Li Z, You Q and Guo Q: Wogonin induced G1 cell cycle arrest by
regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in
human colorectal cancer carcinoma cells. Toxicology. 312:36–47.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao J, Morgan WA, Sanchez-Medina A and
Corcoran O: The ethanol extract of Scutellaria baicalensis and the
active compounds induce cell cycle arrest and apoptosis including
upregulation of p53 and Bax in human lung cancer cells. Toxicol
Appl Pharmacol. 254:221–228. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dong P, Zhang Y, Gu J, Wu W, Li M, Yang J,
Zhang L, Lu J, Mu J, Chen L, et al: Wogonin, an active ingredient
of Chinese herb medicine Scutellaria baicalensis, inhibits the
mobility and invasion of human gallbladder carcinoma GBC-SD cells
by inducing the expression of maspin. J Ethnopharmacol.
137:1373–1380. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang KF, Zhang GD, Huang YQ and Diao Y:
Wogonin induces apoptosis and down-regulates survivin in human
breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Int
Immunopharmacol. 12:334–341. 2012. View Article : Google Scholar
|
|
23
|
Xu M, Lu N, Zhang H, Dai Q, Wei L, Li Z,
You Q and Guo Q: Wogonin induced cytotoxicity in human
hepatocellular carcinoma cells by activation of unfolded protein
response and inactivation of AKT. Hepatol Res. 43:890–905. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin CC, Kuo CL, Lee MH, Lai KC, Lin JP,
Yang JS, Yu CS, Lu CC, Chiang JH, Chueh FS, et al: Wogonin triggers
apoptosis in human osteosarcoma U-2 OS cells through the
endoplasmic reticulum stress, mitochondrial dysfunction and
caspase-3-dependent signaling pathways. Int J Oncol. 39:217–224.
2011.PubMed/NCBI
|
|
25
|
Lee DH, Lee TH, Jung CH and Kim YH:
Wogonin induces apoptosis by activating the AMPK and p53 signaling
pathways in human glioblastoma cells. Cell Signal. 24:2216–2225.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsai CF, Yeh WL, Huang SM, Tan TW and Lu
DY: Wogonin induces reactive oxygen species production and cell
apoptosis in human glioma cancer cells. Int J Mol Sci.
13:9877–9892. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang M, Liu LP, Chen Y, Tian XY, Qin J,
Wang D, Li Z and Mo SL: Wogonin induces apoptosis in RPMI 8226, a
human myeloma cell line, by downregulating phospho-Akt and
overexpressing Bax. Life Sci. 92:55–62. 2013. View Article : Google Scholar
|
|
28
|
Yang H, Hui H, Wang Q, Li H, Zhao K, Zhou
Y, Zhu Y, Wang X, You Q, Guo Q, et al: Wogonin induces cell cycle
arrest and erythroid differentiation in imatinib-resistant K562
cells and primary CML cells. Oncotarget. 5:8188–8201.
2014.PubMed/NCBI
|
|
29
|
Xu X, Zhang Y, Li W, Miao H, Zhang H, Zhou
Y, Li Z, You Q, Zhao L and Guo Q: Wogonin reverses multi-drug
resistance of human myelogenous leukemia K562/A02 cells via
downregulation of MRP1 expression by inhibiting Nrf2/ARE signaling
pathway. Biochem Pharmacol. 92:220–234. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Attia SM, Ahmad SF, Harisa GI, Mansour AM,
El Sayed SM and Bakheet SA: Wogonin attenuates etoposide-induced
oxidative DNA damage and apoptosis via suppression of oxidative DNA
stress and modulation of OGG1 expression. Food Chem Toxicol.
59:724–730. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Masoud L, Vijayasarathy C,
Fernandez-Cabezudo M, Petroianu G and Saleh AM: Effect of malathion
on apoptosis of murine L929 fibroblasts: a possible mechanism for
toxicity in low dose exposure. Toxicology. 185:89–102. 2003.
View Article : Google Scholar
|
|
32
|
Alnemri ES: Mammalian cell death
proteases: a family of highly conserved aspartate specific cysteine
proteases. J Cell Biochem. 64:33–42. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuwana T and Newmeyer DD: Bcl-2-family
proteins and the role of mitochondria in apoptosis. Curr Opin Cell
Biol. 15:691–699. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang Y, Li XJ, Chen Z, Zhu XX, Wang J,
Zhang LB, Qiang L, Ma YJ, Li ZY, Guo QL, et al: Wogonin induced
calreticulin/annexin A1 exposure dictates the immunogenicity of
cancer cells in a PERK/AKT dependent manner. PLoS One.
7:e508112012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lindholm D, Wootz H and Korhonen L: ER
stress and neurode-generative diseases. Cell Death Differ.
13:385–392. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou J, Liu CY, Back SH, Clark RL, Peisach
D, Xu Z and Kaufman RJ: The crystal structure of human IRE1 luminal
domain reveals a conserved dimerization interface required for
activation of the unfolded protein response. Proc Natl Acad Sci
USA. 103:14343–14348. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Winnay JN and Kahn CR: PI 3-kinase
regulatory subunits as regulators of the unfolded protein response.
Methods Enzymol. 490:147–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rutkowski DT and Kaufman RJ: A trip to the
ER: coping with stress. Trends Cell Biol. 14:20–28. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Schröder M and Kaufman RJ: ER stress and
the unfolded protein response. Mutat Res. 569:29–63. 2005.
View Article : Google Scholar
|
|
40
|
Pfaffenbach KT and Lee AS: The critical
role of GRP78 in physiologic and pathologic stress. Curr Opin Cell
Biol. 23:150–156. 2011. View Article : Google Scholar :
|
|
41
|
Li J, Ni M, Lee B, Barron E, Hinton DR and
Lee AS: The unfolded protein response regulator GRP78/BiP is
required for endoplasmic reticulum integrity and stress-induced
autophagy in mammalian cells. Cell Death Differ. 15:1460–1471.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Youle RJ and Strasser A: The BCL-2 protein
family: opposing activities that mediate cell death. Nat Rev Mol
Cell Biol. 9:47–59. 2008. View Article : Google Scholar
|
|
43
|
Lessene G, Czabotar PE and Colman PM:
BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov.
7:989–1000. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vogler M, Dinsdale D, Dyer MJ and Cohen
GM: Bcl-2 inhibitors: small molecules with a big impact on cancer
therapy. Cell Death Differ. 16:360–367. 2009. View Article : Google Scholar
|
|
45
|
Chung H, Jung YM, Shin DH, Lee JY, Oh MY,
Kim HJ, Jang KS, Jeon SJ, Son KH and Kong G: Anticancer effects of
wogonin in both estrogen receptor-positive and -negative human
breast cancer cell lines in vitro and in nude mice xenografts. Int
J Cancer. 122:816–822. 2008. View Article : Google Scholar
|
|
46
|
McCubrey JA, Lee JT, Steelman LS, Blalock
WL, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA,
et al: Interactions between the PI3K and Raf signaling pathways can
result in the transformation of hematopoietic cells. Cancer Detect
Prev. 25:375–393. 2001.PubMed/NCBI
|
|
47
|
Hu P, Han Z, Couvillon AD and Exton JH:
Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in
counteracting endoplasmic reticulum stress-induced cell death. J
Biol Chem. 279:49420–49429. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim SJ, Kim HJ, Kim HR, Lee SH, Cho SD,
Choi CS, Nam JS and Jung JY: Antitumor actions of baicalein and
wogonin in HT-29 human colorectal cancer cells. Mol Med Rep.
6:1443–1449. 2012.PubMed/NCBI
|
